Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-May-24 4:15 PM View:  | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 01-May-24 | Payment of Exercise | 985 | $1.77 | $1,743.45 | (< 1%) 181.09K to 180.11K | |
| 03-May-24 4:15 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 01-May-24 | Payment of Exercise | 917 | $1.77 | $1,623.09 | (< 1%) 191.15K to 190.24K | |
| 03-May-24 4:15 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 01-May-24 | Payment of Exercise | 2,751 | $1.77 | $4,869.27 | (< 1%) 815.48K to 812.73K | |
| 03-May-24 4:15 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 01-May-24 | Payment of Exercise | 1,146 | $1.77 | $2,028.42 | (1%) 112.85K to 111.71K | |
| 05-Mar-24 4:15 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 01-Mar-24 | Payment of Exercise | 12,657 | $2.27 | $28,731.40 | (2%) 828.14K to 815.48K | |
| 05-Mar-24 4:15 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 01-Mar-24 | Payment of Exercise | 5,576 | $2.27 | $12,657.50 | (3%) 186.67K to 181.09K | |
| 05-Mar-24 4:15 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 01-Mar-24 | Payment of Exercise | 6,310 | $2.27 | $14,323.70 | (3%) 197.46K to 191.15K | |
| 08-Feb-24 5:05 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 06-Feb-24 | Payment of Exercise | 1,033 | $2.32 | $2,396.56 | (< 1%) 187.7K to 186.67K | |
| 08-Feb-24 5:06 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 06-Feb-24 | Payment of Exercise | 985 | $2.32 | $2,285.20 | (< 1%) 198.45K to 197.46K | |
| 08-Feb-24 5:10 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 06-Feb-24 | Payment of Exercise | 1,180 | $2.32 | $2,737.60 | (1%) 114.03K to 112.85K | |
| 08-Feb-24 5:08 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 06-Feb-24 | Payment of Exercise | 2,788 | $2.32 | $6,468.16 | (< 1%) 830.92K to 828.14K | |
| 31-Jan-24 7:35 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 29-Jan-24 | Grant | 150,000 | -- | -- | 22% 680.92K to 830.92K | |
| 31-Jan-24 7:36 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 29-Jan-24 | Grant | 53,750 | -- | -- | 40% 133.95K to 187.7K | |
| 31-Jan-24 7:34 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 29-Jan-24 | Grant | 50,000 | -- | -- | 34% 148.45K to 198.45K | |
| 31-Jan-24 7:38 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 29-Jan-24 | Grant | 62,500 | -- | -- | 121% 51.53K to 114.03K | |
| 08-Nov-23 4:14 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 06-Nov-23 | Payment of Exercise | 876 | $1.82 | $1,594.32 | (< 1%) 134.83K to 133.95K | |
| 08-Nov-23 4:12 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 06-Nov-23 | Payment of Exercise | 834 | $1.82 | $1,517.88 | (< 1%) 146.48K to 145.65K | |
| 08-Nov-23 4:10 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 06-Nov-23 | Payment of Exercise | 999 | $1.82 | $1,818.18 | (2%) 52.53K to 51.53K | |
| 08-Nov-23 4:13 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 06-Nov-23 | Payment of Exercise | 2,361 | $1.82 | $4,297.02 | (< 1%) 683.29K to 680.92K | |
| 06-Sep-23 4:29 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 01-Sep-23 | Payment of Exercise | 5,576 | $2.67 | $14,887.90 | (4%) 140.4K to 134.83K | |
| 06-Sep-23 4:31 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 01-Sep-23 | Payment of Exercise | 6,310 | $2.67 | $16,847.70 | (4%) 152.79K to 146.48K | |
| 06-Sep-23 4:28 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 01-Sep-23 | Payment of Exercise | 12,657 | $2.67 | $33,794.20 | (2%) 695.94K to 683.29K | |
| 09-Aug-23 4:37 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 07-Aug-23 | Payment of Exercise | 834 | $2.67 | $2,226.78 | (< 1%) 153.63K to 152.79K | |
| 09-Aug-23 4:29 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 07-Aug-23 | Payment of Exercise | 2,361 | $2.67 | $6,303.87 | (< 1%) 698.3K to 695.94K | |
| 09-Aug-23 4:31 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 07-Aug-23 | Payment of Exercise | 999 | $2.67 | $2,667.33 | (2%) 53.53K to 52.53K | |
| 09-Aug-23 4:38 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 07-Aug-23 | Payment of Exercise | 875 | $2.67 | $2,336.25 | (< 1%) 141.28K to 140.4K | |
| 10-May-23 4:19 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 08-May-23 | Payment of Exercise | 2,361 | $4.14 | $9,774.54 | (< 1%) 700.66K to 698.3K | |
| 10-May-23 4:14 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 08-May-23 | Payment of Exercise | 969 | $4.14 | $4,011.66 | (2%) 54.5K to 53.53K | |
| 10-May-23 4:18 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 08-May-23 | Payment of Exercise | 875 | $4.14 | $3,622.50 | (< 1%) 142.15K to 141.28K | |
| 10-May-23 4:16 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 08-May-23 | Payment of Exercise | 834 | $4.14 | $3,452.76 | (< 1%) 154.46K to 153.63K | |
| 02-Mar-23 6:37 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 01-Mar-23 | Payment of Exercise | 5,576 | $5.51 | $30,723.80 | (4%) 147.73K to 142.15K | |
| 02-Mar-23 6:35 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 01-Mar-23 | Payment of Exercise | 6,310 | $5.51 | $34,768.10 | (4%) 160.77K to 154.46K | |
| 02-Mar-23 6:39 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 01-Mar-23 | Payment of Exercise | 12,657 | $5.51 | $69,740.10 | (2%) 713.32K to 700.66K | |
| 08-Feb-23 4:22 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 06-Feb-23 | Grant | 45,500 | -- | -- | 39% 115.27K to 160.77K | |
| 08-Feb-23 4:28 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 06-Feb-23 | Grant | 128,750 | -- | -- | 22% 584.57K to 713.32K | |
| 08-Feb-23 4:23 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 06-Feb-23 | Grant | 54,500 | -- | -- | 100% 0 to 54.5K | |
| 08-Feb-23 4:18 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 06-Feb-23 | Grant | 47,750 | -- | -- | 48% 99.98K to 147.73K | |
| 09-Dec-22 4:32 PM View: | Ra Capital Management, LLC Director 10% Owner | Vor Biopharma Inc. (VOR) | 09-Dec-22 | Grant | 11,627,900 | $4.30 | $50,000,000.00 | 105% 11.12M to 22.75M | |
| 15-Sep-22 4:18 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 13-Sep-22 | Grant | 172,500 | -- | -- | 42% 412.07K to 584.57K | |
| 06-Sep-22 4:17 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 01-Sep-22 | Grant | 76,000 | -- | -- | 362% 20.98K to 96.98K | |
| 06-Sep-22 4:14 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 01-Sep-22 | Grant | 86,000 | -- | -- | 294% 29.27K to 115.27K | |
| 18-Nov-21 8:10 PM View: | Parmar Kush Director 10% Owner | Vor Biopharma Inc. (VOR) | 16-Nov-21 | Market Sale | 330,706 | $15.30 | $5,059,800.00 | (5%) 6.69M to 6.36M | < 1% |
| 18-Nov-21 8:14 PM View: | 5am Ventures Vi, L.P. 10% Owner | Vor Biopharma Inc. (VOR) | 16-Nov-21 | Market Sale Duplicate | 330,706 | $15.30 | $5,059,800.00 | (5%) 6.69M to 6.36M | < 1% |
| 19-Aug-21 4:02 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 17-Aug-21 | Option Exercise | 17,446 | $1.36 | $23,726.60 | 494% 3.53K to 20.98K | |
| 05-Apr-21 4:33 PM View: | Ra Capital Management, LLC Director 10% Owner | Vor Biopharma Inc. (VOR) | 01-Apr-21 | Acquisition (other) | 998,382 | $43.10 | $43,030,300.00 | 12% 8.3M to 9.3M | |
| 09-Feb-21 5:22 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 09-Feb-21 | Conversion | 3,534 | -- | -- | 14% 25.73K to 29.27K | |
| 09-Feb-21 6:25 PM View: | Ra Capital Management, LLC Director 10% Owner | Vor Biopharma Inc. (VOR) | 09-Feb-21 | Purchase | 2,979,570 | $18.00 | $53,632,200.00 | 42% 7.14M to 10.12M | |
| 09-Feb-21 5:15 PM View: | Parmar Kush Director 10% Owner | Vor Biopharma Inc. (VOR) | 09-Feb-21 | Conversion | 6,136,870 | -- | -- | 100% 0 to 6.14M | |
| 09-Feb-21 6:03 PM View: | 5am Ventures Vi, L.P. 10% Owner | Vor Biopharma Inc. (VOR) | 09-Feb-21 | Conversion Duplicate | 6,136,870 | -- | -- | 100% 0 to 6.14M | |
| 09-Feb-21 7:40 PM View: | Alexandria Venture Investme... 10% Owner | Vor Biopharma Inc. (VOR) | 09-Feb-21 | Conversion | 282,804 | -- | -- | 100% 0 to 282.8K |
